Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

Pierre Fenaux, Sylvie Chevret, A. Guerci, Nathalie Fegueux, Hervé Dombret, Xavier Thomas, Miguel Á. Sanz, H. Link, F. Maloisel, Claude Gardin, Dominique Bordessoule, A. M. Stoppa, Alain Sadoun, Petra Muus, H. Wandt, Philippe Mineur, J.A. Whittaker, Martin F. Fey, M-T Daniel, Sylvie Castaigné, L Degos, for the European APL group

Leukemia

August 1, 2000

10.1038/sj.leu.2401859

Cited by 170

Abstract

Related Papers

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier|Springer series in statistics|1992|45.5k

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia

Meng‐Er Huang, YC Ye, S R Chen et al.|Blood|1988|2.4k

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

Akira Kakizuka, Wilson H. Miller, Kazuhiko Umesono et al.|Cell|1991|1.5k

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Pierre Fenaux, Claude Chastang, Sylvie Chevret et al.|Blood|1999|745

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

Pierre Fenaux, M. Le Deley, Sylvie Castaigné et al.|Blood|1993|519